Fundraising Fox
/Companies
Sign in

iCHOR

North Webster, US · Founded 2014 · 4 known investors

Find your way into iCHOR

Each arrow is one introduction. Sign up to fill in the first one.

44 people can intro you to Tim

Ask Sean Morris to introduce you to Tim Blair

You →Sean · together at Euphrates Vascular →Tim

Sign up to find every way you can get introduced to iCHOR

  • Your email: who you already know at iCHOR, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the iCHOR team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

iCHOR develops minimally-invasive mechanical thrombectomy systems for treating peripheral vascular occlusions, converting traditional open surgical techniques into endovascular procedures for patients with arterial and venous disease.

HealthtechMedical Devices

Founders & leadership

iCHOR was founded in 2014 by Dr. Troy Long and Tim Blair.

DT
Dr. Troy LongFounder
TBTim Blair
Tim BlairFounderTim Blair is founder and CEO of iCHOR Vascular, a medical device company developing minimally-invasive mechanical thrombectomy systems for peripheral vascular disease. He brings over 30 years of experience in medical device leadership, including prior roles managing P&Ls in the cardiovascular and vascular markets, and has led FDA regulatory approvals and commercialization across multiple product platforms.
JBJEFF BLAIR
JEFF BLAIRChairman of the Board

Investors · 4

Arieal Southeast Angel Partnerslisted by Arieal Southeast Angel PartnersSavannah · $100K – $2M

How we know: Arieal Southeast Angel Partners's portfolio page · Not right? Tell us

Band of Angelslisted by Band of AngelsSilicon Valley
Central Texas Angel Networklisted by Central Texas Angel NetworkAustin

How we know: Central Texas Angel Network's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$3.1M disclosed across 2 rounds · 2016–2024

▶$2.9MraisedFeb 2024 · 54 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Timothy BlairExecutive Officer, Director
  • Andrew GreenfieldDirector
  • Craig BerkyDirector
  • Troy LongDirector
  • Mark PetersonDirector
  • Surindra MitrukaDirector
  • Jeffrey BlairDirector
Offering amount
$6M
Amount sold
$2.9M
Minimum investment
$5K
First sale
Jan 2024
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$202.5KraisedMay 2016 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • TROY LONGExecutive Officer, Director
  • JEFF BLAIRExecutive Officer, Director
Offering amount
$202.5K
Amount sold
$202.5K
First sale
Apr 2016
Incorporated
Corporation, Minnesota, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Ichor Vascular has filed a notice of an exempt offering of securities to raise $6,000,000.00 in New Equity Investment. - intelligence360intelligence360.news · Feb 2024

Frequently asked questions

What does iCHOR do?
iCHOR develops minimally-invasive mechanical thrombectomy systems for treating peripheral vascular occlusions, converting traditional open surgical techniques into endovascular procedures for patients with arterial and venous disease.
Who founded iCHOR?
iCHOR was founded by Dr. Troy Long, Tim Blair in 2014.
Who are iCHOR's investors?
iCHOR's investors include Alliance of Angels, Arieal Southeast Angel Partners, Band of Angels, Central Texas Angel Network.
How much funding has iCHOR raised?
iCHOR has disclosed $3.1M raised across 2 rounds.
Where is iCHOR headquartered?
iCHOR is headquartered in North Webster, US.